• Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Achieving Treatment Success for Patients with Heart Failure Complicated by Hyponatremia

Achieving Treatment Success for Patients with Heart Failure Complicated by Hyponatremia

Format

Webcast

Time to Complete

1.50 hours

Released

November 27, 2012

Expires

October 14, 2014

Maximum Credits

1.50 / AMA PRA Category 1 Credit(s)TM
1.50 / CE for Nurses
1.50 / CE for Pharmacists

Accredited Provider

Jointly sponsored by The Foundation for Care Management and CME-University

Commercial Supporter

This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Program Description

Hyponatremia is very difficult to treat in patients with heart failure, and improved treatment strategies represent an urgent clinical need. Recently, vasopressin has emerged as a therapeutic target in the management of hyponatremia. Vasopressin is a central modulator in hyponatremia, underscoring the importance of antagonizing vasopressin at its receptors in patients with hyponatremia and underlying heart failure. Guidelines for the treatment of hyponatremia have been published by several professional associations. The varying recommendations and emerging data on treatment options create challenges for practitioners caring for patients with hyponatremia. Recognizing the possible consequences of unmanaged hyponatremia in heart failure patients and implementing appropriate treatment strategies are critical steps toward improving outcomes in patients with hyponatremia.

Intended Audience

This activity is intended for physicians, nurses, pharmacists, and other health professionals involved in the care of patients with heart failure.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Review the role of arginine vasopressin in the pathogenesis of hypervolemic hyponatremia in patients with heart failure
  • Assess the safety and efficacy of current and emerging therapies for the management of hyponatremia in patients with heart failure
  • Discuss evidence-based guidelines and strategies on the management of hypervolemic hyponatremia in acute decompensated heart failure

Faculty

WELCOME AND INTRODUCTION
John R. Teerlink, FACC, FAHA, FESC, FRCP — Course Chair

Professor of Medicine, University of California, San Francisco (UCSF)
Director, Heart Failure Program SFVAMC
Director, Clinical Echocardiography, SFVAMC
San Francisco VA Medical Center
San Francisco, CA

John R. Teerlink, FACC, FAHA, FESC, FRCP
I will not discuss off-label use or investigational use in my presentation.
I have no financial relationships to disclose.

HYPERVOLEMIC HYPONATREMIA IN PATIENTS WITH HEART FAILURE: PATHOGENESIS AND TREATMENT OPTIONS
Joseph G. Verbalis, MD

Professor of Medicine and Physiology
Chief, Division of Endocrinology and Metabolism
Co-Director, Georgetown-Howard Universities Center for Clinical and Translational Science
Georgetown University Medical Center
Washington, DC

Joseph G. Verbalis, MD
I will not discuss off-label use or investigational use in my presentation.
I have financial relationships to disclose: Consultant/Advisory Board: Astellas, CardioKine, Otsuka America Pharmaceutical, and Sanofi-Aventis

LESSONS FROM CLINICAL TRIALS OF VASOPRESSIN RECEPTOR ANTAGONISTS IN HEART FAILURE
Marvin A. Konstam, MD, FACC

Professor of Medicine, Tufts University School of Medicine
Chief Physician Executive of The Cardiovascular Center
Tufts Medical Center
Boston, MA

Marvin A. Konstam, MD, FACC
I will not discuss off-label use or investigational use in my presentation.
I have financial relationships to disclose: Consultant/Advisory Board: Astellas, CardioKine, Otsuka America Pharmaceutical, and Sanofi-Aventis

CURRENT GUIDELINES AND TREATMENT OPTIONS FOR IMPROVING OUTCOMES IN THE HEART FAILURE PATIENT WITH HYPONATREMIA
Paul Hauptman, MD

Professor of Internal Medicine, Division of Cardiology
Assistant Dean, Clinical and Translational Research
Saint Louis University Hospital
Saint Louis, MO

Paul Hauptman, MD
I will not discuss off-label use or investigational use in my presentation.
I have financial relationships to disclose: Speaker Honorarium: Otsuka America Pharmaceutical
Consultant/Advisory Board: Elsevier, BG Medical, and Otsuka America Pharmaceutical

CARING FOR HEART FAILURE PATIENTS WITH HYPONATREMIA: A NURSING PERSPECTIVE
Linda J. Ordway, RN, MSN, ACNPc

Nurse Practitioner
Tufts Medical Center
Boston, MA

Linda J. Ordway, RN, MSN, ACNPc
I will not discuss off-label use or investigational use in my presentation.
I have financial relationships to disclose: Speaker Honorarium: Otsuka America Pharmaceutical

Medium

Internet

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Foundation for Care Management (FCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

FCM designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of the participation in the activity.

Credit

1.50

Type

CE for Nurses

Accreditation Statement

The Foundation for Care Management is an approved provider of continuing nursing education by the Washington State Nurses Association Continuing Education Approval & Recognition Program (CEARP), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit

1.50

Type

CE for Pharmacists

Accreditation Statement

The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-9999-12-031-H01-P.
*This CE activity is knowledge-based.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

Method of Participation:
To receive continuing education credit, participants should review all program materials in their entirety, complete and submit the online post-test and evaluation, and score at least 70% on the post-test. A statement of credit will be available for printing upon successful completion.

If you have any questions about this CME/CE activity, please e-mail any questions to info@cme-university.org.

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue